185 related articles for article (PubMed ID: 34931675)
1. Economic evaluations of interventions against influenza at workplaces: systematic review.
Ofori SK; Hung YW; Schwind JS; Diallo K; Babatunde D; Nwaobi SO; Hua X; Sullivan KL; Cowling BJ; Chowell G; Fung ICH
Occup Med (Lond); 2022 Feb; 72(2):70-80. PubMed ID: 34931675
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
Jones C; Verstappen SMM; Payne K
Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.
Ferro A; Bordin P; Benacchio L; Fornasiero F; Bressan V; Tralli V; Moretti F; Majori S
Ann Ig; 2020; 32(3):234-244. PubMed ID: 32266361
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
[TBL] [Abstract][Full Text] [Related]
5. Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
Verelst F; Beutels P; Hens N; Willem L
Vaccine; 2021 Apr; 39(14):2005-2015. PubMed ID: 33632564
[TBL] [Abstract][Full Text] [Related]
6. The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review.
Anderson LJ; Shekelle P; Keeler E; Uscher-Pines L; Shanman R; Morton S; Aliyev G; Nuckols TK
Am J Prev Med; 2018 Feb; 54(2):299-315. PubMed ID: 29362167
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
[TBL] [Abstract][Full Text] [Related]
8. Workplace influenza vaccination in private hospital setting: a cost-benefit analysis.
Tohiar MAH; Jaafar S; Aizuddin AN; Leong TK; Abdul Rahim AS
Ann Occup Environ Med; 2022; 34():e3. PubMed ID: 35425620
[TBL] [Abstract][Full Text] [Related]
9. Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.
Blanchet Zumofen MH; Frimpter J; Hansen SA
Pharmacoeconomics; 2023 Mar; 41(3):253-273. PubMed ID: 36515814
[TBL] [Abstract][Full Text] [Related]
10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.
Pérez Velasco R; Praditsitthikorn N; Wichmann K; Mohara A; Kotirum S; Tantivess S; Vallenas C; Harmanci H; Teerawattananon Y
PLoS One; 2012; 7(2):e30333. PubMed ID: 22393352
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
[TBL] [Abstract][Full Text] [Related]
14. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
[TBL] [Abstract][Full Text] [Related]
15. Economic costs of influenza-related work absenteeism.
Akazawa M; Sindelar JL; Paltiel AD
Value Health; 2003; 6(2):107-15. PubMed ID: 12641861
[TBL] [Abstract][Full Text] [Related]
16. Workplace involvement improves return to work rates among employees with back pain on long-term sick leave: a systematic review of the effectiveness and cost-effectiveness of interventions.
Carroll C; Rick J; Pilgrim H; Cameron J; Hillage J
Disabil Rehabil; 2010; 32(8):607-21. PubMed ID: 20205573
[TBL] [Abstract][Full Text] [Related]
17. Workplace vaccination against influenza in Malaysia: does the employer benefit?
Samad AH; Usul MH; Zakaria D; Ismail R; Tasset-Tisseau A; Baron-Papillon F; Follet A
J Occup Health; 2006 Jan; 48(1):1-10. PubMed ID: 16484757
[TBL] [Abstract][Full Text] [Related]
18. Influenza in workplaces: transmission, workers' adherence to sick leave advice and European sick leave recommendations.
Edwards CH; Tomba GS; de Blasio BF
Eur J Public Health; 2016 Jun; 26(3):478-85. PubMed ID: 27060594
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
[TBL] [Abstract][Full Text] [Related]
20. Prevention of relapsing backache.
Lühmann D; Stoll S; Burkhardt-Hammer T; Raspe H
GMS Health Technol Assess; 2006 May; 2():Doc12. PubMed ID: 21289963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
